Evidence-based treatment planning in mCRC- The key to maximising outcomes

Evidence-based treatment planning in mCRC- The key to maximising outcomes

December 30, 2013 at 7:21 AM 0 comments

Summary of Presentations from the Roche Sponsored Satellite Symposium, European Cancer Congress 2013, Amsterdam, the Netherlands Chairperson: Dirk Arnold1 Speakers: Eric Van Cutsem,2 Sharlene Gill3 1. Medical Director of the Hubertus Wald Tumor Center at the University Cancer Center, Hamburg, Germany 2. Professor of Internal Medicine, Head of Digestive Oncology, University Hospital Gathuisberg, Leuven,Read More

Genomic testing in international guidelines

Genomic testing in international guidelines

November 1, 2013 at 7:43 AM 0 comments

Peter Kern,1,2 Mahdi Rezai,2 Christian Singer,3 Rainer Kimmig1 1. University Hospital of Essen, Women´s Department, Comprehensive Cancer Center, Essen, Germany 2. Breast Center of Düsseldorf, Luisenkrankenhaus, Düsseldorf, Germany 3. Professor of Clinical-Translational Gynaecological Oncology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria Disclosure: No potential conflict of interest. Received:Read More

Yoga as Treatment for Insomnia Among Cancer Patients and Survivors: A Systematic Review

Yoga as Treatment for Insomnia Among Cancer Patients and Survivors: A Systematic Review

October 29, 2013 at 8:01 AM 0 comments

Karen M. Mustian University of Rochester Medical Center, James P. Wilmot Cancer Center, Department of Surgery, New York, USA Disclosure: No potential conflict of interest. Support: Funding was provided by NCI U10CA037420, K07CA120025. Received: 22.08.13 Accepted: 29.10.13 Citation: EMJ Oncol. 2013;1:106-115. Abstract Between 15-90% of cancer patients and survivors report someRead More

Key Advances in the Systemic Therapy for Soft tissue Sarcomas: Current Status and Future Directions

Key Advances in the Systemic Therapy for Soft tissue Sarcomas: Current Status and Future Directions

October 28, 2013 at 7:58 AM 0 comments

Neelesh Soman,1 James Hu,2 Vivek Subbiah,3 and Sant Chawla1 1. Sarcoma Oncology Center, Santa Monica, CA, USA 2. University of Southern California, Los Angeles, CA, USA 3. The University of Texas, MD Anderson Cancer Center, Houston, TX, USA Disclosure: No potential conflict of interest. Received: 20.09.13 Accepted: 28.10.13 Citation: EMJ Oncol.Read More

Intensity-Modulated Radiotherapy in the Treatment of Pancreatic Adenocarcinoma – A Review

Intensity-Modulated Radiotherapy in the Treatment of Pancreatic Adenocarcinoma – A Review

October 28, 2013 at 7:54 AM 0 comments

Luciana Caravatta,1,6 Gabriella Macchia,1 Francesco Deodato,1 Marco Felicetti,1 Francesco Cellini,2 Antonella Ciabattoni,3 Milly Buwenge,4 Vincenzo Picardi,1 Savino Cilla,5 Andrea Scapati,6 Vincenzo Valentini,7 Alessio G. Morganti1,7 1. Radiation Oncology Department, Fondazione di Ricerca e Cura “Giovanni Paolo II,” Università Cattolica del S. Cuore, Campobasso, Italy 2. Radiotherapy Department, Università Campus Biomedico,Read More

Prostate cancer and inflammation: The role of miRNAs

Prostate cancer and inflammation: The role of miRNAs

October 28, 2013 at 7:36 AM 0 comments

Sabina Davidsson, Jessica Carlsson Department of Urology, Örebro University Hospital, Örebro, Sweden, and School of Health and Medical Sciences, Örebro University, Sweden. Members of the Trans-disciplinary Prostate Cancer Partnership (ToPCaP) Disclosure: No potential conflict of interest. Received: 26.08.13 Accepted: 28.10.13 Citation: EMJ Oncol. 2013;1:56-60. Abstract Approximately 15-20% of all human cancersRead More

Extreme Hypofractionated Image-Guided Radiotherapy for Prostate Cancer

Extreme Hypofractionated Image-Guided Radiotherapy for Prostate Cancer

October 28, 2013 at 7:30 AM 0 comments

Carlo Greco Director of Clinical Research, Champalimaud Centre for the Unknown (CCU), Lisbon, Portugal Disclosure: No potential conflict of interest. Received: 27.09.13 Accepted: 28.10.13 Citation: EMJ Oncol. 2013;1:48-55. Abstract An emerging body of data suggests that hypofractionated radiation schedules, where a higher dose per fraction is delivered in a smaller numberRead More

New Cervical Cancer Screening Guidelines on Both Sides of the Atlantic

New Cervical Cancer Screening Guidelines on Both Sides of the Atlantic

October 23, 2013 at 7:51 AM 0 comments

Paolo Giorgi Rossi,1 Massimo Vicentini2 1. Director, Servizio Interaziendale di Epidemiologia, AUSL Reggio Emilia, Italy 2. Senior Epidemiologist,Servizio Interaziendale di Epidemiologia, AUSL Reggio Emilia, Italy Disclosure: No potential conflict of interest. Received: 23.09.13 Accepted: 23.10.13 Citation: EMJ Oncol. 2013;1:80-89. Abstract Large population-based trials showed that the human papillomavirus (HPV) DNA testRead More

Role of Positron Emission Tomography with Fluorodeoxyglucose in Prostate Cancer

Role of Positron Emission Tomography with Fluorodeoxyglucose in Prostate Cancer

September 23, 2013 at 7:42 AM 0 comments

Yiyan Liu Associate Professor, Department of Radiology, New Jersey Medical School, New Jersey, USA Disclosure: No potential conflict of interest. Received: 26.06.13 Accepted: 23.09.13 Citation: EMJ Oncol. 2013;1:61-67. Abstract Fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET/CT) has undergone explosive growth in clinical applications and has emerged as one of the mostRead More

Metastasis of Ductal Breast Carcinoma to the Vagina – A Case Report

Metastasis of Ductal Breast Carcinoma to the Vagina – A Case Report

September 13, 2013 at 7:50 AM 0 comments

Leila Cristina Soares, Anna Candida Andrade de Camaret Rio de Janeiro State University, Rio de Janeiro, Brazil Disclosure: No potential conflict of interest. Received: 01.04.13 Accepted: 13.09.13 Citation: EMJ Oncol. 2013;1:76-79. Abstract Primary cancers of the vagina are rare, and so vaginal tumours are likely to represent metastasis from another site.Read More